Screening and surveillance for colorectal cancer

Seminars in Oncology

Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 10-21

  Schnoll Sussman, F ^a   Markowitz, A J ^a   Winawer, S J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLONOSCOPY; COLORECTAL CARCINOMA; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FAMILIAL CANCER; FAMILY HISTORY; GARDNER SYNDROME; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD TEST; PRIORITY JOURNAL; RISK FACTOR; SIGMOIDOSCOPY; ULCERATIVE COLITIS;

COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMAN; MASS SCREENING; OCCULT BLOOD; PRACTICE GUIDELINES; RISK FACTORS; SIGMOIDOSCOPY; SUPPORT, NON-U.S. GOV'T;

EID: 0033786936     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (95)

1. Cancer statistics, 1998
2. Prevention of colorectal cancer by colonoscopic polypectomy
3. Natural history of untreated colonic polyps
4. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas
5. Reducing mortality from colorectal cancer by screening for fecal occult blood
6. Initial mass screening for colorectal cancer with fecal occult blood test
7. Randomised study of screening for colorectal cancer with faecal-occult-blood test
8. Randomized controlled trial of fecal occult blood screening for colorectal cancer: The results of the first 107,349 subjects
9. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
10. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood
11. Screening and rescreening for colorectal cancer: A controlled trial of fecal occult blood testing in 27,700 subjects
12. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects
13. Screening for colorectal cancer with fecal occult blood testing and simoidoscopy
14. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study
15. Effectiveness of colorectal cancer screening: Results from a population-based case-control evaluation in Saarland, Germany
16. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
17. Screening sigmoidoscopy and colorectal cancer mortality
18. The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute
19. Prevention of colorectal cancer by once-only sigmoidoscopy
20. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening
21. Colorectal cancer screening: Clinical guidelines and rationale
22. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997
23. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests
24. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
25. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
26. Screening colonoscopy in asymptomatic average-risk african-americans
27. Prospective study of the frequency and size distribution of polyps missed by colonoscopy
28. Double contrast enema and colonoscopy in polyp detection
29. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: Aspects of decision-making in general practice
30. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps
31. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding
32. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy
33. Flexible sigmoidoscopy plus air contrast barium enema versus colonoscopy for suspected lower gastrointestinal bleeding
34. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive hemoccult test
35. Epidemiology of polyps and cancer
36. The National Polyp Study: Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas
37. Morphology, anatomic distribution and cancer potential of colonic polyps: An analysis of 7,000 polyps endoscopically removed
38. Is the adenomacarcinoma sequence contradicted by the differing location of colorectal adenomas and carcinomas?
39. Remnants of adenomas in colorectal carcinomas
40. The evolution of cancer of the colon and rectum
41. The National Polyp Study: Design, methods, and characteristics of patients with newly diagnosed polyps
42. Adenomatous lesions of the large bowel: An autopsy study
43. Surveillance intervals after colonoscopic polypectomy
44. A prospective colonoscopic follow-up study of 500 adenoma patients with multivariate analysis to predict risk of subsequent colorectal tumors
45. Interet de la surveillance des malades polypectomises dan de prevention du cancer rectocolique: A propos de 123 cas
46. The National Polyp Study: Temporal sequence of evolving colorectal cancer from the normal colon
47. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)
48. Familial colorectal cancer: Diagnosis and management
49. Risk of colorectal cancer in the families of patients with adenomatous polyps
50. Cancer in inflammatory bowel disease
51. A practical approach to the cancer risk in inflammatory bowel disease
52. Carcinoma of the colon and rectum in inflammatory disease of the intestine
53. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers
54. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice
55. Pre-cancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
56. The risk of colorectal cancer in ulcerative colitis: An epidemiologic study
57. Colorectal cancer in patients with ulcerative colitis: A population study in central Israel
58. Colon cancer in ulcerative colitis
59. Cancer risk in ulcerative colitis: Surveillance of surgery
60. Cancer risk in ulcerative colitis
61. Cancer in universal and left-sided ulcerative colitis: Factors determining risk
62. Screening for cancer in ulcerative colitis
63. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis
64. A comparison of cancer risk in Crohn's disease and ulcerative colitis
65. Increased risk of large bowel cancer in Crohn's disease with colonic involvement
66. Cancer in Crohn's disease: Dispelling the myths
67. Multiple carcinomas of the large intestine: A review of the literature and a study of 261 cases
68. Postoperative surveillance of colorectal carcinoma
69. The effect of preoperative endoscopy on recurrence and survival following surgery for colorectal carcinoma
70. Metachronous colorectal polyps: Comparison of development of colorectal polyps and carcinomas with and without history of polyps
71. Risk and surveillance of individuals with heritable factors for colorectal cancer
72. Localization of the gene for familial adenomatous polyposis on chromosome 5
73. The gene for familial polyposis coli maps to the long arm of chromosome 5
74. Identification of FAP locus genes from chromosome 5q21
75. Identification and characterization of the familial adenomatous polyposis coli gene
76. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
77. Extracolonic cancer in hereditary nonpolyposis colorectal cancer
78. Genetic mapping of a locus predisposing to human colorectal cancer
79. The human mutator gene homolog, MSH 2 and its association with hereditary nonpolyposis colon cancer
80. Mutations of a muts homolog in hereditary nonpolyposis colorectal cancer
81. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary nonpolyposis colon cancer
82. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred
83. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
84. Colonoscopy screening of patients at high familial risk for colorectal cancer
85. Risk and surveillance of individuals with colorectal polyps
86. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
87. Can surveillance intervals be lengthened following colonoscopic polypectomy?
88. Surveillance of patients with chronic ulcerative colitis
89. Surveillance of patients with colorectal adenomas or cancer
90. The cost effectiveness of colorectal cancer screening in average-risk adults
91. Endoscopic colorectal cancer screening: A cost-saving analysis
92. The impact of colorectal cancer screening on life expectancy
93. Screening for colorectal cancer in a high-risk population: Results of a mathematical model